US Stock MarketDetailed Quotes

DRMAW DERMATA THERAPEUTICS INC C/WTS (TO PUR COM)

Watchlist
  • 0.0092
  • 0.00000.00%
Close Apr 18 16:00 ET
0Market Cap0.00P/E (TTM)

About DERMATA THERAPEUTICS INC C/WTS (TO PUR COM) Company

Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410. The company was founded by David F. Hale and Gerald T. Proehl on December 8, 2014 and is headquartered in San Diego, CA.

Company Profile

SymbolDRMAW
Company NameDERMATA THERAPEUTICS INC C/WTS (TO PUR COM)
Listing DateAug 13, 2021
Founded2014
CEOMr. Gerald T. Proehl
MarketNASDAQ
Employees8
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address3525 Del Mar Heights Road,Suite 322
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92130
Phone1-858-800-2543

Company Executives

  • Name
  • Position
  • Salary
  • Gerald T. Proehl
  • Chairman of the Board, President and Chief Executive Officer
  • 505.54K
  • Kyri K. Van Hoose
  • Senior Vice President, Principal Accounting Officer and Chief Financial Officer
  • 378.19K
  • Dr. Christopher J. Nardo, PhD
  • Senior Vice President and Chief Development Officer
  • 393.31K
  • Dr. Maria Bedoya Toro Munera, PhD
  • Senior Vice President, Regulatory Affairs and Quality Assurance
  • --
  • Dr. Wendell D. Wierenga,PhD
  • Independent Director
  • 50.00K
  • Kathleen D. Scott
  • Independent Director
  • 55.00K
  • David F. Hale
  • Lead Independent Director
  • 73.00K
  • Andrew Seth Sandler, M.D.
  • Independent Director
  • 49.00K
  • Dr. Steven J. Mento,PhD
  • Independent Director
  • 44.00K
  • Mary M. Fisher
  • Independent Director
  • 47.50K
  • Brittany K. Bradrick
  • Independent Director
  • 47.50K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg